|
Matt Hurd advises directors and executives on mergers, acquisitions and similar strategic decisions. In addition to sales of public and private companies, corporate governance questions, proxy contests and matters related to executive compensation, he regularly advises corporations like Amgen, Fiserv, Goldman Sachs, Hershey, Medco, Philips and UBS on significant acquisitions and divestitures. Although his practice spans a number of industries, Mr. Hurd has specialized expertise in acquisitions involving financial institutions and financial technology companies and many years of experience with transactions in the pharmaceutical, biotech and medical device industries. He frequently acts for European and Australian clients in business acquisitions in North America, and is regularly engaged in matters involving Latin American clients. Mr. Hurd is based in New York. He is also licensed to practice in California, where he has been actively involved in the development of our technology practice. He regularly speaks at professional gatherings on topics associated with mergers and acquisitions, and works on a variety of associate recruitment and development initiatives within the Firm. Rankings and Recognition The Best Lawyers in America Recognized as a leading lawyer in Mergers & Acquisitions (2008, 2007) | 